VIRO 2025

September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
VIRO 2025

VIRO 2025

Global Voices in Renal Oncology (VIRO) 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Rana McKay with co-chair Yüksel Ürün, the 2025 program will bring together approximately 50 leading renal oncology experts from around the world to share the latest advancements and perspectives in the field.

REGISTRATION

Chair

VIRO 2025

2025 Co-chair

VIRO 2025

CL-1CL-2
VIRO 2025VIRO 2025
VIRO 2025VIRO 2025

Speakers

ImagesName
Archana Ajmera

Archana Ajmera (USA)

Adult Nurse Practitioner at UC San Diego Health

Andre-Fay

Andre P. Fay (Brazil)

Medical Oncologist
Professor of Medicine at PUCRS School of Medicine
Visiting Scientist at Dana-Farber Cancer Institute

Ari Hakimi

Ari Hakimi (USA)

Associate Professor and Urologic Surgeon at Memorial Sloan Kettering Cancer Center

Axel Bex

Axel Bex (UK)

Professor of Urology at University College London
Urologic Surgeon and Consultant Clinical Lead of the Specialist Center for Kidney Cancer at the Royal Free London NHS Foundation Trust

Aris Bamias

Aristotelis Bamias (Greece)

Professor of Internal Medicine-Oncology
National and Kapodistrian University of Athens
2nd Propaedeutic Dept of Internal Medicine ATTIKON University Hospital

Armine Badeyan

Armine Badeyan (Armenia)

Acting Director at Radioisotope Production Center

Bryan Lewis

Bryan Lewis (USA)

CEO & Co-Founder of KidneyCAN
Patient Advocate, NCCN Guidelines Panel – Kidney Cancer
Vice Chair at International Kidney Cancer Coalition (IKCC)

Bradley-McGregor

Brad McGregor (USA)

Director of Clinical Research for the Lank Center for Genitourinary Oncology
Medical Oncologist at the Dana-Farber Cancer Institute 
Assistant Professor of Medicine at the Harvard Medical School
Çağatay Arslan_

Çağatay Arslan (Turkey)

Professor and Medical Oncologist at Medical Park İzmir Hospital

Karima Oualla

Karima Oualla (North Africa)

Professor of Medical Oncology at the Hassan II University Hospital in Morocco

Chad Tang

Chad Tang (USA)

Associate Professor and Radiation Oncologist, MD Anderson Cancer Center
David Braun

David Braun (USA)

Assistant Professor of Medicine at Yale School of Medicine

Elizabeth Liow

Elizabeth Liow (Australia)

Medical Oncologist and Head of Australian KRAB Registry and Adjunct Lecturer at Monash University

Elizabeth-Wulff-Burchfield

Elizabeth Wulff-Burchfield (USA)

Associate Professor and Medical Oncologist at the University of Kansas Health System 

Gang Zhu

Gang Zhu (China)

President of CACA Genitourinary Cancer Holistic Rehabilitation Society
President of Asian Robotic Urologic Society Scientific Committee

Giovanni Luca Ceresoli

Giovanni Luca Ceresoli (Italy)

Head of Pneumology and Oncology Urological Hospital Humanitas Gavazzeni Section
Guillermo de Velasco

Guillermo de Velasco (Spain)

Medical Oncologist at University Hospital 12 de Octubre
Katie Coleman

Katie Coleman (USA)

Founder at OncoLogic Solutions and President of Chromophobe and Oncocytic Tumor Alliance
Kleida-Mati

Kleida Mati (Albania)

Medical Oncologist at Albania American Hospital
Jianhua Zhang

Jianhua Zhang (China)

Chief Physician, Associate Professor, Deputy Director at Department of Nuclear Medicine Peking University First Hospital

Ilya Tsimafeyeu

Ilya Tsimafeyeu (Russia)

Director at the Bureau for Cancer Research
ASCO Central and Eastern Europe Regional Council Member
Lewis Au

Lewis Au (Australia)

GU and GI Medical Oncologist at Peter Mac Cancer Centre
Maite Bourlon

Maite Bourlon (Mexico)

Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México
Chair of the ASCO IDEA Steering Group
Maryam Soleimani

Maryam Soleimani (Canada)

Clinical Assistant Professor at University of British Columbia
Division of Medical Oncology
Medical Oncologist at BC Cancer, Vancouver Centre

Mariam Sargsyan

Mariam Sargsyan (Armenia)

Medical Oncologist at Mikaelyan Institute of Surgery

Panagiotis J. Vlachostergios

Panagiotis J. Vlachostergios (Greece)

Assistant Professor of Clinical Medicine at Weill Cornell Medical College, New York
Consultant Medical Oncologist at IASO Thessalias Medical Center, Greece

Paul A Merguerian

Paul A. Merguerian (USA)

Division Chief Pediatric Urology
Seattle Children's Hospital
Professor of Urology
University of Washington

Padraic O’Malley

Padraic O’Malley (USA)

Clinical Assistant Professor in the University of Florida Department of Urology
Chief of Urologic Oncology.
Pedro Barata

Pedro Barata (USA)

Associate Professor of Medicine at Case Western Reserve University School of Medicine
Director of Clinical Genitourinary Medical Oncology Research Program and Co‑Leader Genitourinary Disease Team at University Hospitals Seidman Cancer Center
Petros Grivas

Petros Grivas (USA)

Clinical Director of the GU Cancer Program at the University of Washington
Raya Saab

Raya Saab (USA)

Chief of Pediatric Oncology and Professor at Stanford University School of Medicine

Raquibul Hannan

Raquibul Hannan (USA)

Professor of Radiation Oncology and Chief of Genitourinary Radiation Oncology Service at UT Southwestern Medical Center 

Ruzanna Papyan

Ruzanna Papyan (Armenia)

Chief of the Pediatric Oncology Clinic at the Pediatric Cancer and Blood Disorders Center of Armenia
Assistant Professor at Yerevan State Medical University
SIOP GHN AYA Working Group Co-Chair
Sumanta Pal

Sumanta Pal (USA)

Professor and Vice Chair of Academic Affairs at City of Hope
Chair of the Kidney and Bladder Cancer Disease Team
Co-director of the Kidney Cancer Program

Tian Zhang

Tian Zhang (USA)

Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center

Payal-Kapur

Payal Kapur (USA)

Professor of Pathologist at UT Southwestern Medical Center

Wenxin (Vincent) Xu

Wenxin (Vincent) Xu (USA)

Assistant Professor of Medicine at the Harvard Medical School
Medical Oncologist at the Dana-Farber Cancer Institute
Yousef Zakharia

Yousef Zakharia (USA)

Vice-Chair of the Genitourinary Malignancy Disease Group and Medical Oncologist at the Mayo Clinic Comprehensive Cancer Center

Yu-Wei Chen

Yu-Wei Chen (USA)

Assistant Professor of Medicine and Medical Oncologist at UC San Diego Health
Zeng Hao

Zeng Hao (China)

Professor of Urology at West China Hospital, Sichuan University

TimeSpeaker

Global Voices in Renal Oncology (VIRO) 2025

September 11, 2025

09:00-09:10 AM EDT

Opening Ceremony

09:10 – 09:30 AM EDT

Tian Zhang (USA)
Current Standard of Care: IO/IO and IO/TKI Combinations

 

09:30 – 09:50 AM EDT

Yüksel Ürün (Turkey)
Personalizing Treatment in the Frontline Setting

09:50 – 10:10 AM EDT

Mariam Sargsyan (Armenia)
The Current State of Renal Oncology in Armenia

10:10 – 10:30 AM EDT

Panagiotis J. Vlachostergios (Greece)
Biomarkers for adjuvant therapy benefit in RCC

10:30 – 10:50 AM EDT

David Braun (USA)
Evolution of Biomarker in the Frontline

10:50 – 11:10 AM EDT

Archana Ajmera (USA)
Management of IO/TKI Toxicity

11:10 – 11:30 AM EDT

Ilya Tsimafeyeu (Russia)
Real-World Evaluation of Treatment approaches and Immunotherapy Outcomes in Russia

11:30 – 11:50 AM EDT

Armine Badeyan (Armenia)
Radiological Assessment of Small Renal Masses

11:50 – 12:10 EDT

Jianhua Zhang (China)
Novel Imaging Integration: PET imaging for characterization of small renal masses

12:10 – 12:30 PM EDT

Aristotelis Bamias (Greece)
The Current State of Renal Oncology in Greece

12:30 – 12:50 PM EDT

TBD
Ablative Therapies: RFA, Cryoablation, Microwave Ablation and SABR

12:50 - 13:10 PM EDT

Padraic O’Malley (USA)
Active Surveillance: Patient Selection and Protocols

13:10-13:30 PM EDT

Maite Bourlon (Mexico)
Panel Discussion: Case-Based Approach to SRM Management

13:30 – 13:50 PM EDT

Maryam Soleimani (Canada)
VHL and Kidney Cancer: the Role of Specialized VHL Clinic

13:50 – 14:10 PM EDT

Lewis Au
Overcoming intratumour heterogeneity in tissue-based biomarkers in clear cell renal cell carcinoma

14:10 – 14:30 PM EDT

TBD 
Global voice

14:30 – 14:50 PM EDT

Ruzanna Papyan (Armenia)
Treating Wilms Tumor in Low-Middle-Income Countries

14:50 – 15:10 PM EDT

TBD
Medical Treatment of Renal Tumors in Children and Young Adults

14:50 – 15:10 PM EDT

Paul A. Merguerian (USA)
Surgical Management of Renal Tumors in Children and Young Adults

15:30 – 15:50 PM EDT

Raya Saab (USA)
Panel Discussion: Challenges and Opportunities of Treating Renal Tumors in Children and Young Adults

15:50 – 16:10 PM EDT

TBD 
Global Voice

16:10 – 16:30 PM EDT

TBD 
Global Voice

16:10 – 16:30 PM CET

Chad Tang (USA)
Radiation Approaches for Oligometastatic Disease

16:30 – 16:50 PM EDT

Raquibul Hannan (USA)
Radiation Approaches for Oligoprogressive Disease

16:50 – 17:10 PM EDT

TBD
Role of CRN in Advanced Disease

17:10 – 17:30 PM EDT

Yousef Zakharia (USA)
Case-Based Discussion: Delayed CRN and Consolidative SBRT

17:30 – 17:50 PM EDT

Elizabeth Liow (Australia)
The Current State of Renal Oncology in Australia

17:50-18:10 PM EDT

Bryan Lewis 
KidneyCan: Patient-Driven Movement to Accelerate Cures

18:10-18:20 PM EDT

Closing Ceremony

September 12, 2025

09:10 – 09:30 AM EDT

Gang Zhu (China)
Robotic Surgery with AI Enhanced Holographic Imaging: Bridging Precision, Efficiency, and Functional Preservation

09:30 – 09:50 AM EDT

Axel Bex (UK)
Neoadjuvant Therapy: Current Evidence and Ongoing Trials

09:50 – 10:10 AM EDT

Brad McGregor (USA)
Adjuvant Therapy: Patient Selection and Treatment Options

10:10 – 10:30 AM EDT

TBD
Global voice

10:30 – 10:50 AM EDT

Ari Hakimi (USA)
Modern Prognostic Models for Localized RCC

10:30 – 10:50 AM EDT

Wenxin (Vincent) Xu (USA)
Management of Post-Surgical Recurrence

11:10 – 11:30 AM EDT

TBD
Panel Discussion: Case-Based Presentation Risk Stratification and Perioperative Management for Localized Disease

11:30 – 11:50 AM EDT

Giovanni Luca Ceresoli (Italy)
The Current State of Renal Oncology in Italy

11:50 – 12:10 EDT

Çağatay Arslan (Turkey)
Chromophobe RCC: Diagnosis and Treatment

12:10 – 12:30 PM EDT

Emre Yekedüz (Turkey)
The Current State of Renal Oncology in Turkey

12:30 – 12:50 PM EDT

Guillermo de Velasco (Spain)
Sarcomatoid RCC: Diagnosis and Treatment

12:50 - 13:10 PM EDT

Payal Kapur (USA) 
Pathologic Evaluation of Variant Histologies in RCC

13:10-13:30 PM EDT

Kleida Mati (Albania) 
The Current State of Renal Oncology in Albania

13:30 – 13:50 PM EDT

TBD 
Global voice

13:50 – 14:10 PM EDT

Katie Coleman
The Fight and the Role of Advocacy

14:10 – 14:30 PM EDT

TBD 
Global voice

14:30 – 14:50 PM EDT

Sumanta Pal (USA)
Papillary RCC: Diagnosis and Treatment

14:50 – 15:10 PM EDT

TBD
Panel Discussion: Evidence-Based Approaches to Variant Histologies

15:10 – 15:30 PM EDT

Karima Oualla (North Africa)
The Current State of Renal Oncology in Morocco

15:30 – 15:50 PM EDT

Pedro Barata (USA)
Treatment Sequencing After IO/TKI Progression

15:50 – 16:10 PM EDT

Yu-Wei Chen (USA)
Integration of HIF2a inhibition in RCC

16:10 – 16:30 PM EDT

Andre P. Fay (Brazil)
The Current State of Renal Oncology in Brazil

16:30 – 16:50 PM EDT

Elizabeth Wulff-Burchfield (USA)
Palliative Care Integration in Advanced RCC

16:50 – 17:10 PM EDT

Rana McKay (USA)
Future Directions: Emerging Agents and Combinations

17:10-17:30 PM EDT

Petros Grivas (USA)
Making a Career in GU Oncology

17:30 – 17:50 PM EDT

Zeng Hao (China)
The Current State of Renal Oncology in China

17:50-18:00 PM EDTClosing Ceremony